Skip to main content
Elsevier
View Cart

Books in Drug discovery

BooksJournals

    • Medicinal Plants

      • 2nd Edition
      • February 1, 2026
      • Da-Cheng Hao + 1 more
      • English
      • Hardback
        9 7 8 0 4 4 3 4 1 7 8 3 2
      • eBook
        9 7 8 0 4 4 3 4 1 7 8 4 9
      Medicinal Plants: Chemistry, Biology, and Omics, Second Edition is a reference to help researchers identify and master the patterns in the distribution of medicinal compounds on the phylogenetic tree to explore new drug resources and develop novel therapies against different diseases. The book provides a deeper understanding of how the interrelationship between phytometabolites, bioactivities and omics techniques facilitates sustainable conservation and application of phytomedicine resources. Now in 2nd edition, the contents have been updated to include topics as machine learning applications, geographic distribution of phytometabolites, comparative analysis of alkaloids, expanded coverage of selected taxa, and conditions like cardiovascular disease and cancer. The book is structured around chemotaxonomy. After an introduction and review of taxonomy, chemistry, biology and omics, the authors dive into a taxon-guided exploration of medicinal resources for Fritillaria, Chelidoniae, Dichocarpum, Aconitum, Cimicifugeae, Clematis, Potentilla, Rubus, Cannabis, and other taxa. All chapters follow a similar and consistent structure, offering detailed information on each of them. Researchers in phytopharmacology can acquire in-depth understanding of the interrelationships between chemistry, biology and omics, as well as the implications of the link between phylogeny, phytometabolites and bioactivities in medical biotechnology and sustainability. Clinicians can better understand the principles of mutual interactions between phytometabolites and drug efficacy.

    • Natural Product Drug Discovery

      • 1st Edition
      • February 1, 2026
      • Ning Li + 1 more
      • English
      • Paperback
        9 7 8 0 4 4 3 4 0 5 7 8 5
      • eBook
        9 7 8 0 4 4 3 4 0 5 7 9 2
      Natural Product Drug Discovery: Highly Anticipated Natural Molecules provides a comprehensive examination of the role of natural products in innovative drug development. This research level reference addresses the significant challenges that highly active natural molecules face in the drug development process, including issues related to bioavailability and potency. The book presents detailed analyses of various classes of natural products, including polysaccharides, volatile oils, and diterpenoids, exploring their chemical properties, biological activities, and potential clinical applications. Each chapter is authored by leading experts in the field, offering insights into structural modification techniques, naturally sourced inhibitors, and the application of green biomanufacturing strategies to enhance drug development. This volume in the Drug Discovery Opinion series serves as an essential resource for researchers, pharmacologists, and industry professionals involved in natural product drug discovery. It provides the necessary information to navigate the complexities of this field, emphasizing the integration of traditional knowledge with modern scientific approaches. Through a thorough understanding of these natural compounds, this book aims to contribute to the advancement of therapeutic innovations in pharmacotherapy.

    • Drug Discovery

      • 1st Edition
      • April 1, 2026
      • Renren Bai
      • English
      • Paperback
        9 7 8 0 4 4 3 4 0 5 1 5 0
      • eBook
        9 7 8 0 4 4 3 4 0 5 1 6 7
      Drug Discovery: Traditional Approaches and Advanced Strategies is a foundational monograph connecting established methodologies and cutting-edge technologies, reflecting the transformative impact of AI and other emerging tools in the drug discovery landscape. As the pharmaceutical industry navigates rapid advancements, understanding these trends is vital for enhancing research efficiency and improving clinical success rates. The book is structured into three comprehensive parts. Part I provides an overview of drug discovery and development, introducing current trends and the evolving landscape of the field. Part II explores traditional approaches alongside advanced strategies, covering topics such as drug target discovery, lead optimization, and the revolutionary role of artificial intelligence in drug discovery. Part III investigates promising emerging technologies, including targeted protein degradation and innovative design strategies, equipping readers with insights into the future of drug development. Drug Discovery: Traditional Approaches and Advanced Strategies is a vital resource for academic and industrial researchers, students, and professionals seeking to stay at the forefront of drug discovery. By integrating traditional methodologies with the latest advancements, this book not only enhances understanding but also inspires innovation. With practical case studies and real-world applications, it empowers researchers to implement new technologies effectively, ultimately improving the efficiency and success rates of their R&D endeavors.

    • Antimicrobial Therapeutics and Drug Discovery

      • 1st Edition
      • March 1, 2026
      • Chengyuan Liang + 1 more
      • English
      • Paperback
        9 7 8 0 4 4 3 3 6 5 1 8 8
      • eBook
        9 7 8 0 4 4 3 3 6 5 1 9 5
      Antimicrobial Therapeutics and Drug Discovery is a comprehensive resource that provides an overview of antimicrobial drug discovery. It covers a wide spectrum of pathogenic organisms causing human infections, exploring alternative therapeutic strategies beyond traditional small molecule drugs. The contents in the book are structured into four parts, each focusing on a different aspect of antimicrobial drug discovery. From exploring viral and host targets, understanding antibiotic resistance mechanisms, to the potential of nanomedicine and computational approaches, the book offers a comprehensive view of the field. Employing a multidisciplinary approach, chapters discuss the importance of drug discovery for fungi, Mycobacteria, Mycoplasma, and parasites, and offers insights into innovative biomedical approaches and combination therapies. By bridging the gap between experimental research and practical application, Antimicrobial Therapeutics and Drug Discovery is a key reference for pharmacologists and pharmaceutical scientists working in academic and corporate research. Medicinal chemists and microbiologists will also benefit from the multidisciplinary coverage of the book.

    • Chalcones

      • 1st Edition
      • April 1, 2026
      • Simone Carradori + 2 more
      • English
      • Paperback
        9 7 8 0 4 4 3 4 3 8 1 2 7
      • eBook
        9 7 8 0 4 4 3 4 3 8 1 3 4
      Chalcones: From Drug Discovery to Pharmaceutical Applications serves as a comprehensive reference on chalcones, detailing their natural occurrence, synthetic methods, and therapeutic applications. Chalcones are characterized by their accessible preparation and chemical versatility, making them a focal point for research in drug development. This text aims to provide both novice and experienced researchers with the foundational knowledge necessary to advance their work in this area. The book is organized into three parts. Part I, “Foundations of Chalcones Research,” covers the natural sources of chalcones, various extraction methods, structural characterization techniques, synthesis, and their role in organic chemistry and metal complexes. Part II, “Pharmacology of Chalcones,” addresses pharmacokinetic properties, toxicity, and the medicinal uses of chalcones, including their effectiveness against viruses, bacteria, cancer, and neurodegenerative diseases. Part III, “Prospects,” explores chalcone-containing products, drug formulation strategies, and clinical trials involving chalcone-based drug candidates. This reference is an essential resource for pharmaceutical researchers, providing critical insights into the applications and potential of chalcones in drug development and therapeutic interventions.

    • Synthesis of Best-Seller Drugs

      • 2nd Edition
      • December 1, 2025
      • Ruben Vardanyan + 1 more
      • English
      • Paperback
        9 7 8 0 4 4 3 3 3 8 6 9 4
      • eBook
        9 7 8 0 4 4 3 3 3 8 7 0 0
      Synthesis of Best-Seller Drugs, Second Edition provides detailed information on the most popular drugs, using a practical layout arranged according to drug type. Each chapter reviews the main drugs in each of nearly 40 key therapeutic areas, also examining their classification, novel structural features, models of action, and synthesis. Of high interest to all those who work in the captivating areas of biologically active compounds and medicinal drug synthesis, in particular medicinal chemists, biochemists, and pharmacologists, the book aims to support current research efforts, while also encouraging future developments in this important field.

    • Drug Discovery Approaches for the Treatment of Neurodegenerative Disorders

      • 2nd Edition
      • November 1, 2025
      • Adeboye Adejare
      • English
      • Hardback
        9 7 8 0 4 4 3 3 0 0 0 8 0
      • eBook
        9 7 8 0 4 4 3 3 0 0 0 9 7
      Drug Discovery Approaches for the Treatment of Neurodegenerative Disorders: Alzheimer’s Disease, Second Edition delves into the complexities of drug discovery, specifically for Alzheimer's Disease, presenting the necessary paradigm for future success in research and treatment. This edition is thoroughly updated with recent developments in therapeutic strategies, including amyloid hypothesis, tau, apo E, insulin, and others, and introduces a new chapter on drug delivery to the brain. Additionally, the book encompasses diagnosis, epidemiology, drug discovery strategies, current therapeutics, and more, offering a comprehensive approach to Alzheimer's Disease.It covers the latest in targeted drug design, preclinical studies, and animal models, making it an essential resource for pharmaceutical scientists, pharmacologists, neuroscientists, and clinical researchers. Patients and advocacy groups can also gain valuable insights from the overview of current treatments and scientific advancements in the field.

    • Deep Learning in Drug Design

      • 1st Edition
      • October 1, 2025
      • Qifeng Bai + 2 more
      • English
      Deep Learning in Drug Design: Methods and Applications summarizes the most recent methods, and technological advances of deep learning for drug design, which mainly consists of molecular representations, the architectures of deep learning, geometric deep learning, large models, etc., as well as deep learning applications in various aspects of drug design. This book offers a comprehensive academic overview of deep learning in drug design. It begins with molecular representations, CNNs, GNNs, Transformers, generative models, explainable AI, large models, etc. Next, it covers deep learning applications like protein structure prediction, molecular interactions, ADMET prediction, antibody design, and so on. Finally, a separate chapter is dedicated to the introduction of the ethics and regulation of artificial intelligence in drug design. This book is ideal for readers aiming to learn and implement deep learning methods and applications in drug design and related fields.Deep Learning in Drug Design: Methods and Applications is particularly helpful to undergraduate, graduate, and doctoral students in need of a practical guide to the principles of the discipline. Established researchers in the area will benefit from the detailed case studies and algorithms presented.

    • Emerging Trends in Phytotherapy of Cancer

      • 1st Edition
      • December 1, 2025
      • Mahendra Rai + 1 more
      • English
      • Paperback
        9 7 8 0 4 4 3 4 0 5 1 1 2
      • eBook
        9 7 8 0 4 4 3 4 0 5 1 2 9
      Emerging Trends in Phytotherapy of Cancer is an essential reference that explores the multifaceted role of medicinal plants in combating cancer. The book covers a broad range of interconnected topics including ethnomedicinal plants used in cancer by tribes and aboriginals, herbs used in Ayurvedic medicine for cancer, integrated approaches of modern and conventional drugs, anti-cancerous secondary metabolites, plant-based anticancer drugs approved by FDA and WHO, toxicity to humans, and the role of emerging technologies such as the applications of nanotechnology and artificial intelligence. The contents are divided into six parts. Part one opens with an introductory chapter, followed by the different combinations of plant-based drugs and modern medicine for cancer treatment, and recent developments in cancer research. Part two discusses the ethnomedicinal uses of plants in cancer and the role of Ayurvedic herbal medicines in cancer. Part three incorporates the role of secondary metabolites in cancer treatment. Part four elaborates on the plant-based drugs recommended by FDA/WHO. Part five concerns the human phytotoxicity of secondary metabolites, and part six describes the role of emerging nanotechnologies and artificial intelligence in phytotherapy drug delivery and treatment. Targeted at researchers, healthcare professionals, and advanced students in related fields, this book provides technical and in-depth knowledge, contributing to ongoing advancements in cancer treatment. It uniquely integrates ethnomedicinal therapies with modern technologies, offering a comprehensive overview of the research into phytomedicinal cancer therapies.

    • Medicinal Chemistry and Drug Development

      • 1st Edition
      • February 5, 2025
      • Gang Liu
      • English
      • Paperback
        9 7 8 0 4 4 3 2 7 4 0 2 2
      • eBook
        9 7 8 0 4 4 3 2 7 4 0 3 9
      Medicinal Chemistry and Drug Development describes the key events and roles of medicinal chemistry in the discovery and development of lead compounds into drugs, including target identification, which is accomplished by using 30 case studies. This book outlines all the stages of drug development, including the discovery of active compounds, research on the pharmacologicalprope... of molecules, and confirmation of drug targets. The role of the case studies is to show the common factors in the successful development of drugs, thereby showing medicinal chemists how best to explore the scientific pathways when developing new drugs. This makes the book especially relevant for senior university students majoring in pharmaceutical sciences as well as graduate students and researchers.